Get the 5 Tactics in My Longevity Toolkit and my weekly newsletter here (free): [ Ссылка ]
Watch the full episode: [ Ссылка ]
Become a member to receive exclusive content: [ Ссылка ]
This clip is from episode #272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more
In this episode, Peter is joined by David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D., two world-leading experts on rapamycin and mTOR.
In this clip, we discuss:
- Rapamycin’s discovery & history
- The clinical path of rapamycin
- The negative impact of the clinical path of rapamycin
- And more
--------
About:
The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 70 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.
Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan.
Learn more: [ Ссылка ]
Connect with Peter on:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Subscribe to The Drive:
Apple Podcast: [ Ссылка ]
Overcast: [ Ссылка ]
Spotify: [ Ссылка ]
Google Podcasts: [ Ссылка ]
Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: [ Ссылка ]
#rapamycin #longevity #peterattia
